Wong Gang

Partner

Telephone:

+65 6439 4833

EMAIL:

gang.wong@shooklin.com

Practice Areas:

QUALIFICATION:

EDUCATION:

Languages:

Wong Gang specialises in corporate finance, equity capital markets, mergers and acquisitions, listing compliance and governance, China practice, and general corporate advisory.

His areas of practice include initial public offerings, secondary listings, cross-border dual listings, rights issues, issuance of securities and other instruments by companies from Singapore, China, Taiwan, Indonesia, Bermuda and other jurisdictions.

He also advises on mergers and acquisitions, reverse takeovers, direct investments, joint ventures involving listed and private companies in Singapore, China, Taiwan, Indonesia, Bermuda and other jurisdictions.

He is a member of the Ministry of Law’s Advisory Committee for the China-Ready Programme for Singapore’s Legal Industry.

Matter Experience


Capital Markets
  • Acted as issuer counsel for the listing of Yangzijiang Financial Holdings on the Main Board of the Singapore Exchange with a market cap of S$4.3 billion, Yangzijiang Shipbuilding (Holdings) Ltd’s spin-off listing of its investment segment;
  • Acted as Singapore legal counsel to Singapore Food Holdings Limited in relation to its initial public offering on the Growth Enterprise Market (GEM) of the Stock Exchange of Hong Kong which raised approximately HK$23.9 million in May 2020;
  • Acting as Singapore Counsel for CTR Holdings Limited, a Singapore based construction company, in relation to its initial public offering on the Main Board of the Stock Exchange of Hong Kong in January 2020;
  • Acted for S&T Holdings Limited in relation to its initial public offering on the Main Board of the Stock Exchange of Hong Kong which raised approximately HK$91 million in Sep 2019;
  • Acted for HKE Holdings Limited in relation to its initial public offering on the Main Board of the Stock Exchange of Hong Kong which raised approximately HK$110 million in April 2018;
  • Acting as Singapore Counsel for CMON Limited in its transfer of listing from the Growth Enterprise Market (GEM) to Main Board of the Hong Kong Exchange, conducting full blown legal due diligence on the client and its business operations, and issuing Singapore legal opinion on the transaction in November 2019;
  • Acted for China Star Food Holdings Pte Ltd (CSFH) in a reverse takeover involving the proposed acquisition by SGX-listed Brooke Asia Limited (BAL) of the entire issued and paid-up share capital of China Star Food Holdings Pte Ltd from the Vendors for an aggregate purchase consideration of S$168 million, which is to be satisfied fully through the issuance and allotment of 840 million shares by BAL to the Vendors at an issue price of S$0.20 per share (July 2015);
  • Acted for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (the Company) in the placement to investors in PRC, which involved the allotment and issue of 29,564,356 A-Shares in the capital of the Company, which raised total proceeds of approximately RMB 836.1 million (US$131.6 million) in June 2015;
  • Acted for SGX-listed NH Ceramics Ltd on its (i) acquisition of BlackGold Asia Resources Pte Ltd and BlackGold Energy Ltd for an aggregate price of S$187.5 million; and (ii) placement of 86 million shares at S$0.295 per share which raised a total of S$25.37 million in March 2015;
  • Acted for TEE Land Limited (TEE Land), a subsidiary of SGX-listed engineering and integrated real estate company TEE International Limited, in relation to TEE Land’s listing and initial public offering on the Mainboard of the Singapore Exchange to raise approximately S$62.1 million in June 2013;
  • Acted for China XLX Fertiliser Ltd in its issuance of convertible bonds amounting to approximately RMB324 million (approximately US$51 million) to Nitro Capital Limited in December 2011;
  • Advised on the primary listing of China Hu An Cable Holdings Limited on SGX Mainboard in February 2010 and on the company’s listing of 120 million units of Taiwan Depository Receipts on the Taiwan Stock Exchange;
Corporate Mergers and Acquisitions
  • Acted for Star Pharmaceutical Holdings Limited in relation to its mandatory unconditional cash offer for all the issued and paid-up ordinary shares (excluding treasury shares and those already owned, controlled or agreed to be acquired by it) in the capital of the company for approximately S$20.64 million in August 2019, which resulted in the delisting and privatisation of the company;
  • Acted for Singapore-listed dye maker China Fibretech Ltd in the investment of RMB100 million in Bo Dao Road Construction Co (the Company) for the purpose of investing in and building a rural road project in Xingwen county. The investment will result in China Fibretech having an aggregate of 90.91% equity stake in the Company;
  • Acted for Bursa ACE Market-listed Kronologi Asia Berhad in its acquisition of the entire issued and paid-up share capital of Quantum Storage (Hong Kong) Limited. Also advised on its acquisition of the remaining 80% of the issued and paid-up share capital of Quantum Storage (India) Pte Ltd from Quantum Storage (India) Limited;
  • Acted for Tsingshan Holding Group Co, Ltd in the joint venture investment involving a subscription of 57% equity stake in Strand Minerals (Indonesia) Pte Ltd, a wholly owned subsidiary of Eramet SA, to develop the Weda Bay Nickel deposit in Indonesia;
  • Acted for the Vendor in relation to the disposal of a 40% stake in Robert Parker Wine Advocate and website RobertParker.com, the world’s most widely read independent consumers’ guide to fine wine to Michelin, the globally renowned French tire company and owner of the Michelin gourmet restaurant guide;
  • Acted for China Auto Electronics Group Limited (Offeree Company) in relation to a privatisation by a consortium including certain directors of China Auto Electronics Group Limited for approximately S$216 million and its subsequent delisting from the SGX-ST;
  • Acted for XinRen Aluminum Holdings Limited (XinRen) in relation to a privatisation by XinRen’s controlling shareholders and its subsequent delisting from the SGX-ST. The offer price of S$0.60 per share values XinRen at approximately S$782 million;
  • Acted for China XLX Fertiliser Ltd, which is dual listed on the Main Board of the Singapore Exchange (SGX) and The Stock Exchange of Hong Kong Limited (SEHK), in relation to its voluntary delisting from the SGX, whilst retaining its listing on the SEHK, and the cash exit offer by Pioneer Top Holdings Limited (the Offeror) in August 2014;
  • Acted for SGX-listed XinRen Aluminum Holdings Limited, a leading aluminum producer in China, in relation to the acquisition of an additional 30% stake in China Leading International Group Limited for RMB 3.15 billion (US$507.5 million) in July 2014, following the completion of the purchase of the initial stake;
  • Acted for SunVic Chemical Holdings Limited (SunVic) in a proposed joint venture with Arkema Asie SAS, which involves the disposal of all SunVic’s acrylic acid and acrylate esters production facilities for an estimated RMB 3.9 billion in 2014; and
  • Acted for TYJ Group Pte Ltd (TYJ Group) in relation to the RM700 million (S$272.2 million) joint investment by TYJ Group and SGX-listed GSH Corporation Limited’s wholly-owned subsidiary, Borneo Ventures Pte Ltd, in The Sutera Harbour Group Sdn Bhd by way of equity and loan capital in March 2014.

Accolades


IFLR1000
  • Highly Regarded Individual in Corporate and M&A (2018 – 2025)
Legal 500 Asia Pacific
  • Recommended Individual in Capital Markets: Equity and Debt: Local Firms (2025 – 2026)
Chambers Asia Pacific
  • Ranked Individual in Capital Markets (2011 – 2018)
Chambers Global
  • Ranked Individual in Capital Markets (2012 – 2018)
Asialaw Leading Lawyers
  • Leading Lawyer in Corporate and M&A (2014 – 2018)

Relevant Contributions